We are live on ! Find out more
ENTL

Entellus Medical, Inc. Common Stock
ENTL

Delisted

ENTL was delisted on the 27th of February, 2018.

72 hedge funds and large institutions have $377M invested in Entellus Medical, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 16

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

25% more capital invested

Capital invested by funds: $301M → $377M (+$75.1M)

1% less funds holding

Funds holding: 7372 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.79%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.17%
New
7
Increased
28
Reduced
16
Closed
8
Calls
$207K
Puts
Net Calls
+$207K
Net Calls Change
+$207K

ENTL Hedge Fund Activity: Q3 2017 in Review

72 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q3 2017, worth a combined $377M — up 25% from $301M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ENTL and 7 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 28 added.

The largest buyer was Kohlberg Kravis Roberts & Co, opening a new position worth an estimated $24.3M. The largest seller was Cortina Asset Management, exiting entirely with an estimated $6.09M sold.

  • 72 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q3 2017, down from 73 in Q2 2017.
  • Funds reported $377M of Entellus Medical, Inc. Common Stock stock for Q3 2017, up 25% quarter-over-quarter.
  • 7 funds opened new Entellus Medical, Inc. Common Stock positions in Q3 2017 and 8 closed out, a net change of -1 holder.
  • The largest Entellus Medical, Inc. Common Stock buyer in Q3 2017 was Kohlberg Kravis Roberts & Co, an estimated $24.3M added.
  • The largest Entellus Medical, Inc. Common Stock seller in Q3 2017 was Cortina Asset Management, an estimated $6.09M sold.

Based on aggregated 13F filings for Q3 2017.